Just Getting Started at 75

This article first appeared on Smerconish.com on February 15, 2023

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.

Like other doomsayers from Thomas Malthus to Paul Ehrlich, Emanuel’s basic and profound flaw is his lack of imagination about the human project. While he makes an important distinction between “quality of life” and mere “longevity,” he still advances an all-too-familiar ageist approach to life and death that has ignored the tremendous progress from the past few decades. Pessimism like this hinders much-needed awareness of the myriad of medical innovations and societal progress, enabling longer, healthier, and more productive lives well beyond 75.

We must reimagine 21st-century life where 75 plus marks a robust time of engagement and work. Just ask Jane Fonda, Lilly Tomlin, Rita Moreno, or Sally Field in their latest Hollywood adventure, “80 for Brady,” demonstrating for all of us what life after 75 ought to be. Indeed, several of the cast have been diagnosed with diseases Dr. Emanuel claims he would decline treatment for.

Whether Dr. Emanuel is still with us or not, by mid-century, there will be two billion adults over 60 on the planet – double the number today – who will all benefit from the innovation, invention, and creativity that powers the possibility of healthy longevity. We cannot sacrifice the momentum critical to achieving our society’s healthy aging goals to pessimistic, regressive notions of what getting old is “like.”

Nowhere is the collision of outdated, ageist tropes and life-changing innovation more evident than in the field of heart health. For example, heart valve disease is nearly perfectly aligned with aging – it impacts almost 1 in 10 Americans over 75 and 84 million worldwide. While symptoms like chest pain, tiredness, or feeling “off” risk being dismissed as all too common among older adults, they shouldn’t. Valve disease can often be detected with a simple stethoscope check, and innovations developed in just the last few decades mean it can usually be treated with a minimally invasive procedure in patients of all ages. Most importantly, and particularly relevant during American Heart Month, awareness and early detection are critical to improving treatment outcomes and ultimately saving lives.

We must invest in and prepare for the opportunity of healthy aging before it’s too late. Rather than dismiss the innovation pipeline that will support active and productive contributors into “old age,” consider the economic upside. The spending power and financial contributions of those 75 and older across the globe are valued at $15 trillion, which would rank as the third largest economy in the world behind the US and China. Innovation only occurs in an environment and under economic and political systems that encourage it. As our populations continue to age, we have a golden opportunity to create jobs, drive medical progress and improve health outcomes for old and young alike.

Finally, Dr. Emanuel misses the most fundamental point about age demographics in the 21st century. Whether we’re content living until 75 or not, we face an impending demographic tidal wave – our society will soon have more old than young. While individual decisions on how to age are important, society as a whole must prepare for the opportunity that comes with an aging population, or we risk our future to fatalistic arguments about arbitrary expiration dates. It is essential to empower older individuals with autonomy in their healthcare choices and shift the focus from dying at 75 to maintaining health, wealth, and social contributions into older age.

Heart valve disease is one place to start the conversation, and this month is the moment to begin. February is American Heart Month, and on February 22, more than 119 organizations across the U.S. and worldwide – including our organizations, the Alliance for Aging Research and the Global Coalition on Aging – will mark Heart Valve Disease Awareness Day. So join us, get your heart listened to, and tell a friend. It might just save a life.

Lindsay Clarke, JD, is the Senior Vice President of Health Education and Advocacy for the Alliance for Aging Research. Michael Hodin, Ph.D., is CEO of the Global Coalition on Aging (GCOA) and Managing Partner for High Lantern Group.

Source: Smerconish

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.